![](https://endpts.com/wp-content/uploads/2022/04/Arthur-Kuan-CG-Oncology-CEO.jpg)
Arthur Kuan, CG Oncology CEO
#ASCO2022 roundup: CG Oncology builds on head-turning combo data; EQRx doesn’t have a way into US markets
CG Oncology attracted some attention last month at #AACR22 for its early data on its oncolytic virus paired with Merck’s Keytruda for bladder cancer, and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.